Multicenter phase II trial of LN-145 TIL cell therapy plus pembrolizumab in patients with ICI-naïve metastatic NSCLC Meeting Abstract


Authors: Schoenfeld, A. J.; He, K.; Chesney, J.; Garon, E.; Nieva, J.; Sacher, A.; Lee, S.; Graf Finckenstein, F.; Fiaz, R.; Catlett, M.; Chen, G.; Gontcharova, V.; Creelan, B. C.
Abstract Title: Multicenter phase II trial of LN-145 TIL cell therapy plus pembrolizumab in patients with ICI-naïve metastatic NSCLC
Meeting Title: 2023 World Conference on Lung Cancer (IASLC-WCLC)
Journal Title: Journal of Thoracic Oncology
Volume: 18
Issue: 11 Suppl.
Meeting Dates: 2023 Sep 9-11
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2023-11-01
Start Page: S155
Language: English
DOI: 10.1016/j.jtho.2023.09.225
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: MA15.08 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors